1. Home
  2. SNPX vs SGD Comparison

SNPX vs SGD Comparison

Compare SNPX & SGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
  • SGD
  • Stock Information
  • Founded
  • SNPX 2012
  • SGD 2021
  • Country
  • SNPX United States
  • SGD United States
  • Employees
  • SNPX N/A
  • SGD N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • SGD
  • Sector
  • SNPX Health Care
  • SGD
  • Exchange
  • SNPX Nasdaq
  • SGD Nasdaq
  • Market Cap
  • SNPX 3.7M
  • SGD 3.4M
  • IPO Year
  • SNPX N/A
  • SGD N/A
  • Fundamental
  • Price
  • SNPX $3.17
  • SGD $2.52
  • Analyst Decision
  • SNPX Strong Buy
  • SGD
  • Analyst Count
  • SNPX 1
  • SGD 0
  • Target Price
  • SNPX $14.00
  • SGD N/A
  • AVG Volume (30 Days)
  • SNPX 21.6K
  • SGD 108.0K
  • Earning Date
  • SNPX 11-12-2024
  • SGD 01-01-0001
  • Dividend Yield
  • SNPX N/A
  • SGD N/A
  • EPS Growth
  • SNPX N/A
  • SGD N/A
  • EPS
  • SNPX N/A
  • SGD N/A
  • Revenue
  • SNPX N/A
  • SGD $173,188.00
  • Revenue This Year
  • SNPX N/A
  • SGD N/A
  • Revenue Next Year
  • SNPX N/A
  • SGD N/A
  • P/E Ratio
  • SNPX N/A
  • SGD N/A
  • Revenue Growth
  • SNPX N/A
  • SGD N/A
  • 52 Week Low
  • SNPX $2.32
  • SGD $1.45
  • 52 Week High
  • SNPX $8.78
  • SGD $53.80
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 59.31
  • SGD 52.66
  • Support Level
  • SNPX $2.52
  • SGD $2.08
  • Resistance Level
  • SNPX $3.17
  • SGD $2.33
  • Average True Range (ATR)
  • SNPX 0.20
  • SGD 0.21
  • MACD
  • SNPX 0.04
  • SGD 0.07
  • Stochastic Oscillator
  • SNPX 100.00
  • SGD 83.93

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About SGD Safe and Green Development Corporation

Safe & Green Development Corp is a real estate development company that focuses on the development of sites using purpose built, prefabricated modules built from both wood & steel, sourced from one of Safe & Green Holdings factories. The company's business model is flexible and it anticipates developing properties on its own and also through joint ventures in which it partner with third-party equity investors or other developers.

Share on Social Networks: